Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer

被引：0
|
作者：
Li, Y. [1 ]
Chen, Z. [2 ]
Wu, L. [1 ]
Tao, W. [1 ]
机构：
[1] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Tumor Mutation Score; Tumor Mutation Burden; PD-L1;
D O I：
10.1016/j.jtho.2019.08.1545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-40
引用
收藏
页码：S724 / S724
页数：1
相关论文
共 50 条
  • [41] Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer
    Li, Hui
    Zhang, Yongchang
    Xu, Yanjun
    Huang, Zhiyu
    Cheng, Guoping
    Xie, Mingyin
    Zhou, Zichao
    Yu, Yangyang
    Xi, Wenjing
    Fan, Yun
    CELL DEATH & DISEASE, 2022, 13 (12)
  • [42] Clinical factors associated with mutation burden in non-small cell lung cancer
    Ono, A.
    Serizawa, M.
    Omae, K.
    Isaka, M.
    Kojima, H.
    Takahashi, S.
    Nakashima, K.
    Omori, S.
    Wakuda, K.
    Kenmotsu, H.
    Naito, T.
    Murakami, H.
    Urakami, K.
    Ohde, Y.
    Nakajima, T.
    Kusuhara, M.
    Yamaguchi, K.
    Takahashi, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer
    Hui Li
    Yongchang Zhang
    Yanjun Xu
    Zhiyu Huang
    Guoping Cheng
    Mingyin Xie
    Zichao Zhou
    Yangyang Yu
    Wenjing Xi
    Yun Fan
    Cell Death & Disease, 13
  • [44] Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images
    Patkar, Sushant
    Chen, Alex
    Basnet, Alina
    Bixby, Amber
    Rajendran, Rahul
    Chernet, Rachel
    Faso, Susan
    Kumar, Prashant A.
    Desai, Devashish
    El-Zammar, Ola
    Curtiss, Christopher
    Carello, Saverio J.
    Nasr, Michel R.
    Choyke, Peter
    Harmon, Stephanie
    Turkbey, Baris
    Jamaspishvili, Tamara
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [45] Evaluation of Blood Tumor Mutation Burden for Efficacy of Second- Line Atezolizumab Treatment in Non-small Cell Lung Cancer
    Park, C. -K.
    Jun, H. R.
    Oh, H. -J.
    Lee, J. -Y.
    Cho, H. -J.
    Kim, Y. -C.
    Lee, J. E.
    Yoon, S. H.
    Choi, C. M.
    Lee, J. C.
    Lee, S. Y.
    Lee, S. Y.
    Chun, S. -M.
    Oh, I. -J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S345 - S345
  • [46] Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung Cancer to PD-L1 Blockade
    Zhang, Xinmu
    Zhang, Li
    JAMA ONCOLOGY, 2023, 9 (04) : 569 - 570
  • [47] The Landscape of Alteration of DNA Integrity-Related Genes and Their Association with Tumor Mutation Burden in Non-Small Cell Lung Cancer
    Sharpnack, M.
    Cho, J. H.
    Oezkan, F.
    Koenig, M.
    Kim, I.
    Otterson, G.
    Huang, K.
    Carbone, D.
    He, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1795 - S1796
  • [48] Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients
    Zhang, H.
    Deng, Y-M
    Chen, Z-C
    Tang, Y-C
    Yang, S.
    Zhang, S-D
    Liang, J-M
    Wang, Y-G
    Wu, X.
    Zhang, R-W
    Feng, W-N
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (14) : 7664 - 7672
  • [49] Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
    He, Bingxi
    Dong, Di
    She, Yunlang
    Zhou, Caicun
    Fang, Mengjie
    Zhu, Yongbei
    Zhang, Henghui
    Huang, Zhipei
    Jiang, Tao
    Tian, Jie
    Chen, Chang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [50] The Association Between Tumor Burden and the Efficacy of Immunotherapy Among Patients With Non-small Cell Lung Cancer
    Hui, Jia-Jun
    Yan, Han-Lu
    Ding, Sheng-Jun
    Qin, Bao-Dong
    Jiao, Xiao-Dong
    Zang, Yuan-Sheng
    CANCER CONTROL, 2025, 32
12345